--- title: "GZYK: Net profit loss of RMB 1.2455 million in the third quarter, a decrease of 94.36%" type: "News" locale: "en" url: "https://longbridge.com/en/news/262377338.md" description: "GZYK announced that the revenue for the third quarter was 227 million yuan, an increase of 4.82% year-on-year; the net profit loss was 1.2455 million yuan, a decrease of 94.36%. The revenue for the first three quarters was 663 million yuan, a year-on-year decrease of 5.05%; the net profit was 173,400 yuan, an increase of 100.83% year-on-year" datetime: "2025-10-23T08:27:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/262377338.md) - [en](https://longbridge.com/en/news/262377338.md) - [zh-HK](https://longbridge.com/zh-HK/news/262377338.md) --- # GZYK: Net profit loss of RMB 1.2455 million in the third quarter, a decrease of 94.36% GZYK announced that the revenue for the third quarter was 227 million yuan, a year-on-year increase of 4.82%; the net profit loss was 1.2455 million yuan, a decrease of 94.36%. The revenue for the first three quarters was 663 million yuan, a year-on-year decrease of 5.05%; the net profit was 173,400 yuan, a year-on-year increase of 100.83% ### Related Stocks - [002524.CN](https://longbridge.com/en/quote/002524.CN.md) ## Related News & Research - [This New Solar Battery Stores Energy Without Lithium or the Grid](https://longbridge.com/en/news/287211325.md) - [09:15 ETSt. Luke's University Health Network First in the Country to Launch Helix Genomic Advantage™ to Lower Total Cost of Care](https://longbridge.com/en/news/287228090.md) - [London’s Global Healthcare Opportunities and Asia's CBC Group to merge creating investment giant, FT reports](https://longbridge.com/en/news/287011397.md) - [Indonesia’s investment app Pluang raises $10M, expands into equities marketGrows**](https://longbridge.com/en/news/286855201.md) - [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md)